Investment Management Corp of Ontario Sells 300 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Investment Management Corp of Ontario lowered its holdings in shares of Molina Healthcare, Inc. (NYSE:MOHFree Report) by 15.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,597 shares of the company’s stock after selling 300 shares during the quarter. Investment Management Corp of Ontario’s holdings in Molina Healthcare were worth $465,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of MOH. Tributary Capital Management LLC lifted its holdings in shares of Molina Healthcare by 76.1% in the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company’s stock worth $1,219,000 after acquiring an additional 1,811 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Molina Healthcare by 123.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company’s stock worth $100,000 after acquiring an additional 192 shares in the last quarter. SYM FINANCIAL Corp purchased a new stake in Molina Healthcare during the 4th quarter worth approximately $249,000. Summit Trail Advisors LLC purchased a new stake in Molina Healthcare during the 4th quarter worth approximately $452,000. Finally, Entropy Technologies LP grew its position in Molina Healthcare by 58.1% during the 4th quarter. Entropy Technologies LP now owns 4,594 shares of the company’s stock worth $1,337,000 after purchasing an additional 1,688 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Baird R W downgraded shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. UBS Group reduced their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research report on Friday, February 7th. StockNews.com upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, April 11th. Barclays raised their price objective on shares of Molina Healthcare from $339.00 to $362.00 and gave the stock an “equal weight” rating in a research report on Friday, April 25th. Finally, Guggenheim assumed coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a “neutral” rating for the company. Nine analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $365.38.

Get Our Latest Stock Report on Molina Healthcare

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. The trade was a 5.44% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 257,715 shares in the company, valued at $82,484,262.90. This represents a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 89,169 shares of company stock valued at $28,520,995 in the last ninety days. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Stock Up 1.6%

Shares of Molina Healthcare stock opened at $327.47 on Tuesday. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23. The company has a 50 day moving average of $325.04 and a 200 day moving average of $308.39. The company has a market capitalization of $17.75 billion, a P/E ratio of 16.03, a P/E/G ratio of 1.06 and a beta of 0.63.

Molina Healthcare (NYSE:MOHGet Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts’ consensus estimates of $5.96 by $0.12. The company had revenue of $11.15 billion for the quarter, compared to analysts’ expectations of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter last year, the company earned $5.73 earnings per share. As a group, research analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Further Reading

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.